Denis A. Babkov

923 total citations
76 papers, 698 citations indexed

About

Denis A. Babkov is a scholar working on Organic Chemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Denis A. Babkov has authored 76 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Organic Chemistry, 36 papers in Molecular Biology and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Denis A. Babkov's work include Synthesis and biological activity (14 papers), Natural Antidiabetic Agents Studies (12 papers) and Natural product bioactivities and synthesis (8 papers). Denis A. Babkov is often cited by papers focused on Synthesis and biological activity (14 papers), Natural Antidiabetic Agents Studies (12 papers) and Natural product bioactivities and synthesis (8 papers). Denis A. Babkov collaborates with scholars based in Russia, United States and Belgium. Denis A. Babkov's co-authors include А. А. Спасов, О. Б. Казакова, E. V. Sokolova, Михаил С. Новиков, E. F. Khusnutdinova, Anastasia L. Khandazhinskaya, Anastasiya V. Petrova, Katherine L. Seley‐Radtke, G. V. Giniyatullina and Yu. N. Klimochkin and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Denis A. Babkov

74 papers receiving 685 citations

Peers

Denis A. Babkov

EDM

EPIDE

M. Qaiser Fatmi Pakistan

Ana Carolina Rennó Sodero Brazil

Paul Awolade South Africa

Ramanujam Rajagopalan India

Syed Muhammad Saad Pakistan

Y.V. Madhavi India

E. Nicolle France

Ruqaiya Khalil Pakistan

Shama Khan South Africa

Céline Crauste France

M. Qaiser Fatmi Pakistan

Denis A. Babkov

260 ×0.7

268 ×1.0

95 ×1.0

EDM

19 ×0.3

EPIDE

39 ×0.6

Citations per year, relative to Denis A. Babkov Denis A. Babkov (= 1×) peers M. Qaiser Fatmi

Countries citing papers authored by Denis A. Babkov

Since Specialization

Citations

This map shows the geographic impact of Denis A. Babkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis A. Babkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis A. Babkov more than expected).

Fields of papers citing papers by Denis A. Babkov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis A. Babkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis A. Babkov. The network helps show where Denis A. Babkov may publish in the future.

Co-authorship network of co-authors of Denis A. Babkov

This figure shows the co-authorship network connecting the top 25 collaborators of Denis A. Babkov. A scholar is included among the top collaborators of Denis A. Babkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis A. Babkov. Denis A. Babkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petrova, Anastasiya V., et al.. (2025). Spacered With Tetrazole Oleanolic and Ursolic Indolo‐Acids Are Strong Inhibitors of α‐Glucosidase. Chemical Biology & Drug Design. 105(3). e70065–e70065. 2 indexed citations

Babkov, Denis A., et al.. (2024). Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain. International Journal of Molecular Sciences. 25(16). 8841–8841. 2 indexed citations

Tret’yakova, E. V., et al.. (2024). Derivatization of Abietane Acids by Peptide-like Substituents Leads to Submicromolar Cytotoxicity at NCI-60 Panel. Molecules. 29(15). 3532–3532. 1 indexed citations

Politanskaya, Larisa, Jiaying Wang, Владимир В. Зарубаев, et al.. (2024). Efficient synthesis and evaluation of therapeutic potential of fluorine containing 2-arylchromen-4-ones. Molecular Diversity. 29(2). 1427–1452. 3 indexed citations

Смирнова, И. Е., et al.. (2024). A Novel Dipterocarpol Derivative That Targets Alpha‐Glucosidase and NLRP3 Inflammasome Activity for Treatment of Diabetes Mellitus. Chemistry & Biodiversity. 22(1). e202401626–e202401626. 1 indexed citations

Babkov, Denis A., О. В. Безнос, E. V. Sokolova, et al.. (2023). Microwave-assisted synthesis of 5-aryl-3-hydroxy-2-oxindole derivatives and evaluation of their antiglaucomic activity. Mendeleev Communications. 33(4). 550–552. 3 indexed citations

Babkov, Denis A., et al.. (2023). 3-Arylidene-2-oxindoles as GSK3β inhibitors and anti-thrombotic agents. Bioorganic & Medicinal Chemistry Letters. 87. 129283–129283. 2 indexed citations

Спасов, А. А., I.G. Ovchinnikova, О. В. Федорова, et al.. (2023). Amino Derivatives of Diaryl Pyrimidines and Azolopyrimidines as Protective Agents against LPS-Induced Acute Lung Injury. Molecules. 28(2). 741–741. 5 indexed citations

Petrova, Anastasiya V., Denis A. Babkov, E. F. Khusnutdinova, et al.. (2023). α-Glucosidase Inhibitors Based on Oleanolic Acid for the Treatment of Immunometabolic Disorders. Applied Sciences. 13(16). 9269–9269. 10 indexed citations

10.

Саватеев, Константин В., S. K. Kotovskaya, В. Л. Русинов, et al.. (2022). 6-(Tetrazol-5-yl)-7-aminoazolo[1,5-a]pyrimidines as Novel Potent CK2 Inhibitors. Molecules. 27(24). 8697–8697. 4 indexed citations

11.

Petrova, Anastasiya V., et al.. (2022). Selective synthesis of A-ringЕ-arylidene derivatives from β-sitosterol and their activity. Natural Product Research. 38(1). 52–59. 3 indexed citations

12.

Tret’yakova, E. V., И. Е. Смирнова, О. Б. Казакова, et al.. (2022). New Molecules of Diterpene Origin with Inhibitory Properties toward α-Glucosidase. International Journal of Molecular Sciences. 23(21). 13535–13535. 9 indexed citations

13.

Спасов, А. А., et al.. (2022). Guanidine Derivatives of Quinazoline-2,4(1H,3H)-Dione as NHE-1 Inhibitors and Anti-Inflammatory Agents. Life. 12(10). 1647–1647. 2 indexed citations

14.

Спасов, А. А., Denis A. Babkov, E. V. Sokolova, et al.. (2022). Discovery of Nitro-azolo[1,5-a]pyrimidines with Anti-Inflammatory and Protective Activity against LPS-Induced Acute Lung Injury. Pharmaceuticals. 15(5). 537–537. 7 indexed citations

15.

Саватеев, Константин В., Victor V. Fedotov, Oleg S. Eltsov, et al.. (2019). Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents. European Journal of Medicinal Chemistry. 185. 111808–111808. 26 indexed citations

16.

Babkov, Denis A., E. V. Sokolova, Alexandra A. Kolodina, et al.. (2019). Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators. Bioorganic & Medicinal Chemistry Letters. 29(17). 2443–2447. 37 indexed citations

17.

Спасов, А. А., et al.. (2018). Glucokinase activators — a promising class of antidiabetic drugs. Problems of Endocrinology. 64(3). 180–187. 2 indexed citations

18.

Спасов, А. А., et al.. (2018). Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(1). 119–123. 39 indexed citations

19.

Babkov, Denis A., Vladimir T. Valuev-Elliston, А. А. Озеров, et al.. (2015). Scaffold hopping: Exploration of acetanilide-containing uracil analogues as potential NNRTIs. Bioorganic & Medicinal Chemistry. 23(5). 1069–1081. 13 indexed citations

20.

Новиков, Михаил С., Vladimir T. Valuev-Elliston, Denis A. Babkov, et al.. (2013). N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry. 21(5). 1150–1158. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact